This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Omnicell To Exhibit At Dubai International Pharmaceuticals And Technologies Conference And Exhibition

Stocks in this article: OMCL

DUBAI, United Arab Emirates, March 10, 2012 /PRNewswire/ -- Omnicell, Inc., (NASDAQ:OMCL) a leading global provider of medication and supply management solutions and analytics software for healthcare facilities, will exhibit its state-of-the-art G4 technology at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) March 12-14 at the Dubai International Convention & Exhibition Centre. DUPHAT is one of the most recognized and significant pharmaceutical events in the Middle East and North Africa.

"Our vision to meet the automated medication and supply delivery needs of healthcare customers in the Middle East was advanced with the opening of our regional office and training center in Dubai in May 2011," said Gary Ervin, Omnicell vice president of international operations. "Our Dubai Center was the first of its kind to be established by a leading U.S. medication and supply automation company. We are committed to delivering Omnicell's award winning technology and training throughout the Middle East, customized to suit local healthcare requirements."

During the DUPHAT exhibition, attendees will have the opportunity to meet Omnicell experts to discuss medication automation best practices and to see Omnicell's recently introduced G4 medication automation platform in demonstration. The G4 platform features a single unified medication database, the Savvy Mobile Medication System and the newly designed Anesthesia Workstation. Also highlighted will be the new integrated Medication Label Printer, a unique Omnicell solution that supports accurate medication administration with patient-specific labels that are efficiently printed at the mediation cabinet.

Omnicell automation solutions are recognized with top honors by the leading independent rating agency, KLAS, based on extensive interviews of U.S. healthcare executives. For example, Omnicell has achieved the top KLAS distinction six years in a row for the OmniRx® automated medication system as well as "Best in KLAS" distinctions for its Pharmacy Automation Medication Carousels and the KLAS Category Leader award for its Anesthesia Workstation. In customer surveys, Omnicell has been consistently recognized for its innovation and long-term customer satisfaction.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,974.31 -31.44 -0.18%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,549.2260 -15.0680 -0.33%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs